D. A. Starostenko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
D. A. Starostenko has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandr Nikolaevich Konovalov
N.N. Burdenko National Medical Research Center of Neurosurgery, Moscow, Russia
5 shared publications - Fyodor V. Grebenev
N.N. Burdenko National Medical Research Center of Neurosurgery, Moscow, Russia
5 shared publications - Anton Alekseevich Artemyev
N.N. Burdenko National Medical Research Center of Neurosurgery, Moscow, Russia
4 shared publications - Dmitry Nikolaevich Okishev
N.N. Burdenko National Medical Research Center of Neurosurgery, Moscow, Russia
4 shared publications - I. A. Erokhin
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
4 shared publications - S. S. Sergeeva
I.M. Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia
4 shared publications
Latest Publications
- 14 November 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 652
Microsurgery, stereotactic radiosurgery and endovascular treatment of sylvian fissure arteriovenous malformations: a systematic review
- 14 November 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 652
Microsurgery, stereotactic radiosurgery and endovascular treatment of sylvian fissure arteriovenous malformations: a systematic review
- 22 October 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 622
Molecular-genetic mechanisms of cerebral arteriovenous malformations: A systematic review of germline, somatic and experimental evidence
Cerebral arteriovenous malformations (AVMs) are high-flow vascular anomalies that carry a considerable burden of haemorrhagic morbidity. Work over the past decade has shown that both inherited syndromes and apparently sporadic lesions can be traced to alterations in a handful of signalling pathways, but the relevant evidence sits awkwardly between human genetic studies, animal models, and molecular profiling experiments. To bring together the current evidence on the molecular and genetic underpinnings of cerebral AVM formation, clinical course, and candidate therapeutic targets. We searched MEDLINE (PubMed), Embase, Web of Science Core Collection, and Scopus from inception to 1 January 2026. Records were screened, and full texts assessed, by two reviewers working independently. Studies were eligible if they reported genetic, molecular, or epigenetic data on cerebral AVMs. Because of substantial heterogeneity in designs and outcomes, evidence was synthesised qualitatively. Of 343 records, 44 primary studies (28 clinico-genetic and 16 experimental) together with 20 reviews and meta-analyses met inclusion. Inherited AVM syndromes largely reflected germline variants in the TGF-β/BMP network (ENG, ACVRL1, SMAD4, GDF2/BMP9) or in arteriovenous-specification regulators (RASA1, EPHB4); penetrance was incomplete and there was support for local modifying “second-hit” events. Resected sporadic cerebral AVMs often carried somatic activating mutations in the RAS/MAPK cascade—mostly KRAS, less often BRAF—at low variant allele fractions that demanded high-sensitivity assays. Endothelial-specific activation of KRAS or BRAF reproduced AVM-like phenotypes in vivo and showed MEK–ERK dependence. Susceptibility variants (notably at 9p21/ANRIL), inflammatory mediators, extracellular-matrix remodelling, and epigenetic changes appear to fine-tune lesion behaviour and haemorrhagic risk. Syndromic predisposition and clonal somatic events in endothelium converge on a small set of developmental signalling axes that govern angiogenesis and vessel-wall maturation. Diagnostics anchored in this biology, together with pathway-targeted therapy, now need prospective evaluation, paired with standardised approaches for detecting low-level mosaicism.
- 22 October 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 622
Molecular-genetic mechanisms of cerebral arteriovenous malformations: A systematic review of germline, somatic and experimental evidence
Cerebral arteriovenous malformations (AVMs) are high-flow vascular anomalies that carry a considerable burden of haemorrhagic morbidity. Work over the past decade has shown that both inherited syndromes and apparently sporadic lesions can be traced to alterations in a handful of signalling pathways, but the relevant evidence sits awkwardly between human genetic studies, animal models, and molecular profiling experiments. To bring together the current evidence on the molecular and genetic underpinnings of cerebral AVM formation, clinical course, and candidate therapeutic targets. We searched MEDLINE (PubMed), Embase, Web of Science Core Collection, and Scopus from inception to 1 January 2026. Records were screened, and full texts assessed, by two reviewers working independently. Studies were eligible if they reported genetic, molecular, or epigenetic data on cerebral AVMs. Because of substantial heterogeneity in designs and outcomes, evidence was synthesised qualitatively. Of 343 records, 44 primary studies (28 clinico-genetic and 16 experimental) together with 20 reviews and meta-analyses met inclusion. Inherited AVM syndromes largely reflected germline variants in the TGF-β/BMP network (ENG, ACVRL1, SMAD4, GDF2/BMP9) or in arteriovenous-specification regulators (RASA1, EPHB4); penetrance was incomplete and there was support for local modifying “second-hit” events. Resected sporadic cerebral AVMs often carried somatic activating mutations in the RAS/MAPK cascade—mostly KRAS, less often BRAF—at low variant allele fractions that demanded high-sensitivity assays. Endothelial-specific activation of KRAS or BRAF reproduced AVM-like phenotypes in vivo and showed MEK–ERK dependence. Susceptibility variants (notably at 9p21/ANRIL), inflammatory mediators, extracellular-matrix remodelling, and epigenetic changes appear to fine-tune lesion behaviour and haemorrhagic risk. Syndromic predisposition and clonal somatic events in endothelium converge on a small set of developmental signalling axes that govern angiogenesis and vessel-wall maturation. Diagnostics anchored in this biology, together with pathway-targeted therapy, now need prospective evaluation, paired with standardised approaches for detecting low-level mosaicism.
- 16 October 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (5) , 25-31
Intraoperative rupture of cerebral aneurysms during microsurgical clipping as a risk factor of residual aneurysm enlargement
Background. Aneurysm neck clipping is preferable for saccular aneurysms due to stable occlusion. However, postoperative follow-up angiography reveals residual aneurysm in some cases after clipping. Long-term outcomes depend on clipping quality. Currently, there is no consensus regarding further management of these patients. Objective. To analyze residual cerebral aneurysms within the first year after surgery, and to identify prognostic factors of enlargement and rupture of aneurysm remnant. Material and methods. In 2024, clipping of 654 cerebral aneurysms in 550 patients was performed. Residual aneurysms were identified in 49 (7.5%) cases. Clipping quality was estimated in accordance with classification by Yu.V. Pilipenko. Three patients with partial exclusion (R4) underwent redo surgery in early postoperative period. Among 46 patients with residual aneurysms, we enrolled 25 patients with available clinical and angiographic data within one year after surgery. Results. There were no CT signs of residual aneurysm enlargement in 22 (88%) out of 25 cases. In two patients (8%), enlargement of remnant required redo clipping. Fatal rupture of aneurysm remnant occurred in 1 (4%) case. All three patients experienced intraoperative aneurysm rupture during primary surgery. Conclusion. Intraoperative rupture significantly increases the risk of residual aneurysm enlargement. Localization in Anterior communicating artery (ACjoA) and clipping quality ≥R3 are potential risk factors requiring further studies of larger cohorts.
- 16 October 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (5) , 25-31
Intraoperative rupture of cerebral aneurysms during microsurgical clipping as a risk factor of residual aneurysm enlargement
Background. Aneurysm neck clipping is preferable for saccular aneurysms due to stable occlusion. However, postoperative follow-up angiography reveals residual aneurysm in some cases after clipping. Long-term outcomes depend on clipping quality. Currently, there is no consensus regarding further management of these patients. Objective. To analyze residual cerebral aneurysms within the first year after surgery, and to identify prognostic factors of enlargement and rupture of aneurysm remnant. Material and methods. In 2024, clipping of 654 cerebral aneurysms in 550 patients was performed. Residual aneurysms were identified in 49 (7.5%) cases. Clipping quality was estimated in accordance with classification by Yu.V. Pilipenko. Three patients with partial exclusion (R4) underwent redo surgery in early postoperative period. Among 46 patients with residual aneurysms, we enrolled 25 patients with available clinical and angiographic data within one year after surgery. Results. There were no CT signs of residual aneurysm enlargement in 22 (88%) out of 25 cases. In two patients (8%), enlargement of remnant required redo clipping. Fatal rupture of aneurysm remnant occurred in 1 (4%) case. All three patients experienced intraoperative aneurysm rupture during primary surgery. Conclusion. Intraoperative rupture significantly increases the risk of residual aneurysm enlargement. Localization in Anterior communicating artery (ACjoA) and clipping quality ≥R3 are potential risk factors requiring further studies of larger cohorts.
- 30 June 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 7,p. 1163-1170
Effect of VR technology on pain and anxiety levels in patients after cerebral aneurysm clipping
Adequate management of postoperative pain and anxiety in neurosurgical patients remains an urgent task requiring novel non — pharmacological approaches to minimize the adverse effects of traditional pharmacotherapy. This study evaluates the efficacy of virtual reality (VR) as an adjunctive non — pharmacological modality to reduce postoperative pain and anxiety in neurosurgical patients at the N. N. Burdenko National Medical Research Center for Neurosurgery. The study included 62 patients with cerebral aneurysms operated on in the 3rd Yu. M. Filatov Vascular Neurosurgery Department between October 2024 and December 2025. The study compared a main group (n=31, VR therapy) and a control group (n=31). Evaluation criteria included daily Visual Analogue Scale (VAS) scores (postoperative days 1–3), Beck and Zung anxiety levels, pharmacological support volume (analgesics, antiemetics), and therapy adverse effects. A statistically significant pain reduction was observed on days 1, 2, and 3 in the VR group (p < 0.05) compared to the control. The main group showed a decreased need for non — steroidal anti — inflammatory drugs (NSAIDs) on postoperative day 2 (p < 0.05). No statistically significant difference in antiemetic consumption or nausea was found between the groups. Pre– and postoperative anxiety measurements using Beck and Zung scales revealed no significant differences between the cohorts (p > 0.05). Postoperative VR therapy demonstrated a statistically significant pain reduction without adverse effects, confirming the modality’s potential. Despite high clinical significance regarding pain, the method showed no statistically significant impact on patients’ anxiety levels.
- 30 June 2026
- Published by PANORAMA Publishing House in Vestnik Nevrologii, Psihiatrii i Nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery)
- No. 7,p. 1163-1170
Effect of VR technology on pain and anxiety levels in patients after cerebral aneurysm clipping
Adequate management of postoperative pain and anxiety in neurosurgical patients remains an urgent task requiring novel non — pharmacological approaches to minimize the adverse effects of traditional pharmacotherapy. This study evaluates the efficacy of virtual reality (VR) as an adjunctive non — pharmacological modality to reduce postoperative pain and anxiety in neurosurgical patients at the N. N. Burdenko National Medical Research Center for Neurosurgery. The study included 62 patients with cerebral aneurysms operated on in the 3rd Yu. M. Filatov Vascular Neurosurgery Department between October 2024 and December 2025. The study compared a main group (n=31, VR therapy) and a control group (n=31). Evaluation criteria included daily Visual Analogue Scale (VAS) scores (postoperative days 1–3), Beck and Zung anxiety levels, pharmacological support volume (analgesics, antiemetics), and therapy adverse effects. A statistically significant pain reduction was observed on days 1, 2, and 3 in the VR group (p < 0.05) compared to the control. The main group showed a decreased need for non — steroidal anti — inflammatory drugs (NSAIDs) on postoperative day 2 (p < 0.05). No statistically significant difference in antiemetic consumption or nausea was found between the groups. Pre– and postoperative anxiety measurements using Beck and Zung scales revealed no significant differences between the cohorts (p > 0.05). Postoperative VR therapy demonstrated a statistically significant pain reduction without adverse effects, confirming the modality’s potential. Despite high clinical significance regarding pain, the method showed no statistically significant impact on patients’ anxiety levels.
- 3 April 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (2) , 6-14
Microsurgical treatment of cerebral arteriovenous malformations: a 20-year experience of the Burdenko Neurosurgical Center
Objective. To evaluate the results of microsurgical treatment of cerebral arteriovenous malformations (AVMs) over a 20-year period and their dynamics taking into account clinical and morphological characteristics of malformations, baseline functional status of patients and clinically relevant outcome measures. Material and methods. A single-center retrospective cohort study included 1.273 cases of microsurgical treatment of cerebral AVMs between 2006 and 2025. Demographic data, AVM morphology, Spetzler-Martin grading, hemorrhage and seizures before surgery, preoperative embolization, early postoperative complications, and mRS scores before surgery and at discharge were assessed. A favorable outcome implied improvement or no deterioration compared to preoperative status. Clinically significant deterioration («new disability») was defined as deterioration compared to baseline status with mRS ≥3. Visual field defects were analyzed separately and not included in morbidity. Results. In-hospital mortality was 0.6%. Favorable outcomes were observed in 1.165 out of 1.271 patients (91.7%). Clinically significant deterioration («new disability») was observed in 8.3% of patients. The incidence of complications and adverse outcomes increased along with higher Spetzler-Martin grades. Patients with previous hemorrhage were more likely to have baseline neurological deficit, but the incidence of «new disability» in this group was no different from that in patients without hemorrhage. Preoperative embolization was more common in patients with more difficult AVMs. Conclusion. Microsurgical treatment of cerebral AVMs at a specialized center is characterized by low in-hospital mortality and high proportion of favorable functional outcomes.
- 3 April 2026
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 90 (2) , 6-14
Microsurgical treatment of cerebral arteriovenous malformations: a 20-year experience of the Burdenko Neurosurgical Center
Objective. To evaluate the results of microsurgical treatment of cerebral arteriovenous malformations (AVMs) over a 20-year period and their dynamics taking into account clinical and morphological characteristics of malformations, baseline functional status of patients and clinically relevant outcome measures. Material and methods. A single-center retrospective cohort study included 1.273 cases of microsurgical treatment of cerebral AVMs between 2006 and 2025. Demographic data, AVM morphology, Spetzler-Martin grading, hemorrhage and seizures before surgery, preoperative embolization, early postoperative complications, and mRS scores before surgery and at discharge were assessed. A favorable outcome implied improvement or no deterioration compared to preoperative status. Clinically significant deterioration («new disability») was defined as deterioration compared to baseline status with mRS ≥3. Visual field defects were analyzed separately and not included in morbidity. Results. In-hospital mortality was 0.6%. Favorable outcomes were observed in 1.165 out of 1.271 patients (91.7%). Clinically significant deterioration («new disability») was observed in 8.3% of patients. The incidence of complications and adverse outcomes increased along with higher Spetzler-Martin grades. Patients with previous hemorrhage were more likely to have baseline neurological deficit, but the incidence of «new disability» in this group was no different from that in patients without hemorrhage. Preoperative embolization was more common in patients with more difficult AVMs. Conclusion. Microsurgical treatment of cerebral AVMs at a specialized center is characterized by low in-hospital mortality and high proportion of favorable functional outcomes.
- 27 November 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (6) , 76-83
Giant retrosellar arachnoid cyst: a case report and literature review
Background. Arachnoid cysts are predominantly congenital pathologies associated with cleft of arachnoid membrane of spinal cord or brain. Arachnoid cysts present with cerebral, hypertensive-hydrocephalic and focal symptoms. Localization of intracranial arachnoid cysts can vary. Only 12% of symptomatic arachnoid cysts are localized in posterior cranial fossa. Objective. To present successful treatment of a patient with retrosellar arachnoid cyst, review available literature data and compare clinical course and treatment outcomes. Material and methods. A 29-year-old female patient presented with long-term history of headache, dizziness, diplopia and statodynamic disturbances. Magnetic resonance imaging revealed giant retrosellar arachnoid cyst compressing the brainstem and causing hydrocephalus. The PubMed database was screened (2015—2025). Only full-text articles In Russian and English were included. References of these articles comprised secondary searching. Results and discussion. Endoscopic cystoventriculocisternostomy of arachnoid cyst in posterior fossa was performed. Postoperative period was uneventful. Neurological and ophthalmological status was the same. MRI revealed significant improvement including cyst shrinkage and regression of symptoms over a 3-month period. There were only 7 relevant reports. Conclusion. Correct surgical approach is confirmed by cyst shrinkage after surgery and clinical follow-up data.
- 27 November 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (6) , 76-83
Giant retrosellar arachnoid cyst: a case report and literature review
Background. Arachnoid cysts are predominantly congenital pathologies associated with cleft of arachnoid membrane of spinal cord or brain. Arachnoid cysts present with cerebral, hypertensive-hydrocephalic and focal symptoms. Localization of intracranial arachnoid cysts can vary. Only 12% of symptomatic arachnoid cysts are localized in posterior cranial fossa. Objective. To present successful treatment of a patient with retrosellar arachnoid cyst, review available literature data and compare clinical course and treatment outcomes. Material and methods. A 29-year-old female patient presented with long-term history of headache, dizziness, diplopia and statodynamic disturbances. Magnetic resonance imaging revealed giant retrosellar arachnoid cyst compressing the brainstem and causing hydrocephalus. The PubMed database was screened (2015—2025). Only full-text articles In Russian and English were included. References of these articles comprised secondary searching. Results and discussion. Endoscopic cystoventriculocisternostomy of arachnoid cyst in posterior fossa was performed. Postoperative period was uneventful. Neurological and ophthalmological status was the same. MRI revealed significant improvement including cyst shrinkage and regression of symptoms over a 3-month period. There were only 7 relevant reports. Conclusion. Correct surgical approach is confirmed by cyst shrinkage after surgery and clinical follow-up data.
- 4 April 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (2) , 39-47
Analysis of a series of 14 clinical cases of neurosurgical treatment of hypophysitis
Primary hypophysitis is a rare disease that is usually diagnosed retrospectively after surgery for suspected tumors of the sellar region (pituitary adenomas, craniopharyngiomas, etc.). The most common variant of the primary forms is lymphocytic hypophysitis, characterized by the presence of lymphocytes in the inflammatory infiltrate. Granulomatous hypophysitis is the second most common variant of the disease, the cause of which remains unknown. Objective. To study the frequency and nature of clinical manifestations, the features of MRI of the brain, as well as the results of neurosurgical treatment of patients with a confirmed histological diagnosis of hypophysitis. Material and methods. A retrospective analysis of the case reports of 14 patients with histologically confirmed diagnosis of lymphocytic (13 cases) and granulomatous (1 case) hypophysitis operated at the Burdenko Neurosurgical Center. Results. In none of the cases before the operation, according to the MRI data, the diagnosis of “hypophysitis” was made. Clinical symptoms were manifested by headaches in 12 patients, decreased acuity and/or visual field impairment in 9 patients, oculomotor impairments in 2 patients. Hypopituitarism was detected in 12 cases, and diabetes insipidus in 8 cases. After surgery, 7 patients had a regression of headache and improved vision, in 5 cases there was no dynamics, in 1 case vision deteriorated. In all 8 patients with diabetes insipidus, it persisted after surgery. There were no new cases of diabetes insipidus. Panhypopituitarism was noted in all patients. Conclusion. Given the difficulty of diagnosing hypophysitis without morphological verification, as well as the rarity of these cases, prospective multicenter studies are needed to study the pathognomonic signs of hypophysitis and improve their neuroimaging methods.
- 4 April 2025
- Published by Media Sphere Publishing Group in Burdenko's Journal of Neurosurgery
- Vol. 89 (2) , 39-47
Analysis of a series of 14 clinical cases of neurosurgical treatment of hypophysitis
Primary hypophysitis is a rare disease that is usually diagnosed retrospectively after surgery for suspected tumors of the sellar region (pituitary adenomas, craniopharyngiomas, etc.). The most common variant of the primary forms is lymphocytic hypophysitis, characterized by the presence of lymphocytes in the inflammatory infiltrate. Granulomatous hypophysitis is the second most common variant of the disease, the cause of which remains unknown. Objective. To study the frequency and nature of clinical manifestations, the features of MRI of the brain, as well as the results of neurosurgical treatment of patients with a confirmed histological diagnosis of hypophysitis. Material and methods. A retrospective analysis of the case reports of 14 patients with histologically confirmed diagnosis of lymphocytic (13 cases) and granulomatous (1 case) hypophysitis operated at the Burdenko Neurosurgical Center. Results. In none of the cases before the operation, according to the MRI data, the diagnosis of “hypophysitis” was made. Clinical symptoms were manifested by headaches in 12 patients, decreased acuity and/or visual field impairment in 9 patients, oculomotor impairments in 2 patients. Hypopituitarism was detected in 12 cases, and diabetes insipidus in 8 cases. After surgery, 7 patients had a regression of headache and improved vision, in 5 cases there was no dynamics, in 1 case vision deteriorated. In all 8 patients with diabetes insipidus, it persisted after surgery. There were no new cases of diabetes insipidus. Panhypopituitarism was noted in all patients. Conclusion. Given the difficulty of diagnosing hypophysitis without morphological verification, as well as the rarity of these cases, prospective multicenter studies are needed to study the pathognomonic signs of hypophysitis and improve their neuroimaging methods.